Website Header with Language Selector and Dropdowns

N-Nitroso Palbociclib Impurity 2


Catalog Number: CL-PBC-NO-02
CAS No.: NA
Mol.F: C24H27N9O4
Mol.W: 505.53
Inv. Status: Custom Synthesis

Chemical Name: N-(6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)-N-(5-(piperazin-1-yl)pyridin-2-yl)nitrous amide.

Country of Origin: India

Product Category: Palbociclib Impurities


N-Nitroso Palbociclib Impurity 2 is identified by CAS No. NA and is chemically known as N-(6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)-N-(5-(piperazin-1-yl)pyridin-2-yl)nitrous amide.

N-Nitroso Palbociclib Impurity 2 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Palbociclib.

Page Keywords: Buy N-Nitroso Palbociclib Impurity 2 | Purchase N-Nitroso Palbociclib Impurity 2 | N-Nitroso Palbociclib Impurity 2 suppliers | N-Nitroso Palbociclib Impurity 2 manufacturers | N-Nitroso Palbociclib Impurity 2 price | N-Nitroso Palbociclib Impurity 2 Importer | N-Nitroso Palbociclib Impurity 2 Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-PBC-NO-01
CAS No: NA
Mol Wt: 476.53
Mol F: C24H28N8O3
Inv. Status: In Stock
CAT No: CL-PBC-NO-03
CAS No: NA
Mol Wt: 505.529
Mol F: C24H27N9O4
Inv. Status: Custom Synthesis
CAT No: CL-PBC-NO-04
CAS No: NA
Mol Wt: 237.215
Mol F: C9H11N5O3
Inv. Status: In Stock
CAT No: CL-PBC-NO-05
CAS No: NA
Mol Wt: 323.348
Mol F: C14H21N5O4
Inv. Status: Custom Synthesis
CAT No: CL-PBC-NO-06
CAS No: NA
Mol Wt: 613.506
Mol F: C27H33BrN8O4
Inv. Status: Custom Synthesis
CAT No: CL-PBC-NO-07
CAS No: NA
Mol Wt: 632.753
Mol F: C33H44N8O5
Inv. Status: Custom Synthesis
CAT No: CL-PBC-NO-08
CAS No: NA
Mol Wt: 207.232
Mol F: C9H13N5O
Inv. Status: In Stock
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.